Derivative weighted active insulin control modelling and clinical trials for ICU patients

Medical Engineering and Physics

Volumn 26, Issue 10, 2004, Pages 855-866

  Doran, Carmen V ^a   Hudson, Nicolas H ^a   Moorhead, Katherine T ^a   Chase, J Geoffrey ^a   Shaw, Geoffrey M ^b   Hann, Chris E ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Blood glucose; Critical care; Derivative; Feedback control; Hyperglycemia; ICU; Insulin control

Indexed keywords

ALGORITHMS; BIOSENSORS; BLOOD; DISEASES; DRUG INFUSION; FEEDBACK CONTROL; GLUCOSE; MATHEMATICAL MODELS;

BLOOD GLUCOSE LEVELS; DIABETIC; ORAL GLUCOSE TOLERANCE TEST;

INSULIN;

INSULIN;

ADULT; AGED; ALGORITHM; ARTICLE; BEHAVIOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEEDBACK SYSTEM; FEMALE; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HOSPITAL; HUMAN; INTENSIVE CARE UNIT; MALE; MATHEMATICAL MODEL; ORAL GLUCOSE TOLERANCE TEST; PHYSIOLOGY; PRIORITY JOURNAL;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS; DRUG THERAPY, COMPUTER-ASSISTED; FEEDBACK; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN INFUSION SYSTEMS; INTENSIVE CARE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; TREATMENT OUTCOME;

EID: 3242656211     PISSN: 13504533     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medengphy.2004.08.004     Document Type: Article

References (48)

1. Arkray Inc. Glucocard™ test strip 2 data sheet. 2001;Arkray, Inc, Japan
2. Avogaro A., Bristow J.D., Bier D.M., Cobelli C.A. Stable-label intravenous glucose tolerance test minimal models. Diabetes. 38:1989;1048-1055
3. Berger M., Rotbard D. A pharmacodynamic approach to optimising insulin therapy. Computer Methods and Programs in Biomedicine. 34:1991;241-253
4. Bergman R.N., Phillips L.S., Cobelli C. Physiological evaluation of factors controlling glucose tolerance in man. Journal of Clinical Investigation. 68:1981;1456-1467
5. Bergman R.N., Finegood D.T., Ader M. Assessment of insulin sensitivity in vivo. Endocrine Reviews. 6:(1):1985;45-86
6. Boland E.A., Grey M., Oesterle A., Fredrickson L., Tamborlane W.V. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycaemia, improve metabolic control and enhance coping in adolescents with type I diabetes. Diabetes Care. 22:(11):1999;1779-1784
7. Boroujerdi M, Williams C, Carson E, Piwernetz K, Hepp K, Sonksen, P. A simulation approach for planning insulin regimes. International Symposium on Advanced Models for Therapy of Insulin Dependent Diabetes 1987;41-6.
8. Callegari T., Caumo A., Cobelli C. Generalisation of a map estimation in SAAM II: validation against ADAPT II in a glucose model case study. Annals of Biomedical Engineering. 30:2002;961-968
9. Charpentier G., Riveline J.P., Varroud-Vial M. Management of drugs affecting blood glucose in diabetic patients with renal failure. Diabetes and Metabolism. 26:(4):2000;73-85
10. Chase J.G., Lam Z.-H., Lee J.-Y., Hwang K.-S. Active insulin infusion control of the blood glucose derivative. Proceedings of the 7th International Conf on Control, Automation, Robotics and Vision (ICARCV 2002), Singapore, Dec 3-5:2002
11. Chase J.G., Wake G.C., Lam Z.-H., Lee J.-Y., Hwang K.-S., Shaw G.M. Steady state optimal insulin infusion for hyperglycemic ICU patients. Proceedings of the 7th International Conf on Control, Automation, Robotics and Vision (ICARCV 2002), Singapore, Dec 3-5:2002
12. Cherrington A.D., Sindelar D., Edgerton D., Steiner K. Physiological consequences of phasic insulin release in the normal animal. Diabetes. 51:2002;S130-S108
13. Cobelli C., Deferspil G., Pacibi G., Salvan A., Scandellari S. An integrated mathematics model of the dynamics of blood glucose and its hormonal control. Mathematical Biosciences. 58:1982;27-60
14. Cobelli C., Nucci G., Del Prato S. Physiological simulation model of the glucose-insulin system. IEEE Conference on Engineering in Medicine and Biology. Oct 16:1999;999
15. Del Prato S., Marchetti P., Bonadonna R.C. Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes. 51:(1):2002;S109-S116
16. Deutsch T., Carson E.R., Harvey F.E., Lehman E.D., Sonksen P.H., Tamas G., et al. Computer-assisted diabetic management: a complex approach. Computer Methods and Programs in Biomedicine. 32:1990;195-214
17. Doyle F., Dorski C., Harting J., Peppas N. Control and modeling of drug delivery devices for the treatment of diabetes. Proceedings of the American Control Conference, June 21-23:1995;776-780
18. Erzen F.C., Birol G., Cinar A. Simulation studies on the dynamics of diabetes mellitus. IEEE International Symposium on Bio-informatics and Biomedical Engineering, November 8-10:2000;231-235
19. Fisher M.E. A semiclosed-loop algorithm for the control of blood glucose levels in diabetics. IEEE Transactions on Biomedical Engineering. 38:(1):1991;57-61
20. Fisher M.E., Teo K.L. Optimal insulin infusion resulting from a mathematical model of blood glucose dynamics. IEEE Transactions on Biomedical Engineering. 36:(4):1989;479-486
21. Fletcher L., Soden P. Diet construction using linear programming. Diabetes, Nutrition and Metabolism. 1:1991;169-174
22. Furler S.M., Edward W., Smallwood R.H., Chisholm D.J. Blood glucose control by intermittent loop closure in the basal mode: computer simulation studies with a diabetic model. Diabetes Care. 8:(6):1985;553-561
23. Gonzalez-Michaca L., Ahumada M., Ponce-de-Leon S. Insulin subcutaneous application vs. continuous infusion for postoperative blood glucose control in patients with non-insulin-dependent diabetes mellitus. Archives of Medical Research. 33:(1):2002;48-52
24. Guyton A.C., Hall J.E. Textbook of medical physiology. 9th ed:1996;Elsevier Science, Philadelphia (PA)
25. Home P.D., Massi-Benedetti M., Gill G.V., Capaldo B., Shepherd G.A., Alberti K.G. Impaired subcutaneous absorption of insulin in 'brittle' diabetics. Acta Endocrinology. 101:1982;414-420
26. Kienitz K., Yoneyama T. Robust controller for insulin pumps based on H-infinity theory. IEEE Transactions on Biomedical Engineering. 40:(11):1993;1133-1137
27. Kraegen E.W., Chisolm D.J. Insulin responses to carting profiles of subcutaneous insulin infusion: kinematics modelling studies. Diaetologia. 26:1984;208-213
28. Lam Z.-H., Lee J.-Y., Hwang K.-S., Chase J.G., Wake G.C. Active insulin infusion using optimal and derivative-weighted control. Journal of Medical Engineering and Physics. 24:(10):2002;663-672
29. Lehman E., Deutsch T. AIDA: a mk. II automated insulin dosage advisor. Journal of Biomedical Engineering. 15:1993;201-211
30. Lehman E., Deutsch T. Computer assisted diabetes care: a 6-year retrospective. Computer Methods and Programs in Biomedicine. 50:1996;209-230
31. Naylor J., Hodel A., Morton B., Schumacher D. Automatic control issues in the development of an artificial pancreas. Proceedings of ACC:1995;771-775
32. Ollerton R. Application of optimal control theory to diabetes mellitus. International Journal of Control. 50:(6):1989;2503-2522
33. Parker R., Doyle F., Harting J., Peppas N. Model predictive control for infusion pump insulin delivery. IEEE Conference of Engineering in Medicine and Biology, November 3:1996;1822-1823
34. Peters A.L., Davidson M.B., Schriger D.L., Hasselblad Vic. A clinical approach for the diagnosis of diabetes mellitus. JAMA. 276:(15):1996;1246-1252
35. Phillips D.I.W., Clark P.M., Hales C.N., Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabetic Medicine. 11:1994;286-292
36. Pickup J., Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type I diabetes. Diabetes Care. 25:(3):2002;593-598. Mar
37. Schrezenmeir J. Computer aids in dietetics. Diabetes, Nutrition and Metabolism. Suppl 1:1991;175-191
38. Simeoni M., Caumo A., Rizza R., Cobelli C. Modelling glucose control on endogenous glucose production on state: necessity of direct and delayed signalling. Proceeding of the 19 International Conference of the IEEE Engineering in Medicine and Biology Society. 5:1997;2138-2141
39. Sobngwi E., Mauvais-Jarvis F., Vexiau P., Mbanya J.C., Gautier J.F. Diabetes in Africans. Part 2: Ketosis-prone atypical diabetes mellitus. Diabetes and Metabolism. 28:(1):2002;5-12. Feb
40. Skyler J., Skyler D., Seigler D., Sullivan M. Algorithms for adjustment of insulin dosage. Diabetes Care. 4:1981;311-318
41. Thomson S, Beaven D, Jamieson M, Snively S, Howl A, Christophersen A. Type 2 diabetes: managing for better health outcomes. Price-WaterHouse-Coopers Report, Diabetes New Zealand Inc., 2001.
42. Toschi E., Camastra S., Sironi A.M., Masoni A., Gastaldelli A., Mari A., et al. Effect of acute hyperglycemia on insulin secretion in humans. Diabetes. 51:2002;S130-S133
43. Trajonoski Z., Wach P. Evaluation of subcutaneous route for the closed-loop control of insulin delivery: Numerical and experimental studies. IEEE Conference on Engineering in Medicine and Biology, Sep 20-23:1995;1357-1358
44. Trajonoski Z., Wach P. Neural predictive controller for insulin delivery using the sub-cutaneous route. IEEE Transactions on Biomedical Engineering. 45:(9):1998;1122-1134
45. Van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schietz M., et al. Intensive insulin therapy in critically ill patients. New England Journal of Medicine. 345:(19):2001;1359-1367
46. Votey R.S., Peters A.L. Diabetes mellitus, Type 1 - a review. eMedicine Journal. 2:(4):2001;. Available from: http://www.emedicine.com/EMERG/topic133. htm
47. Votey R.S., Peters A.L. Diabetes mellitus, Type 2 - a review. eMedicine Journal. 3:(4):2002;. Available from: http://www.emedicine.com/EMERG/topic134. htm
48. Xiao J., Gregersen S., Pederson S.B., Hermansen K. Differential impact of acute and chronic lipotoxicity on gene expression in INS-1 cells. Metabolism: Clinical and Experimental. 51:(2):2002;155-162